RECOMBINANT HUMAN ACTIVATED PROTEIN C (rhAPC) PRODUCES A TREND TOWARD IMPROVEMENT IN MORBIDITY AND 28 DAY SURVIVAL IN PATIENTS WITH SEVERE SEPSIS
- 1 January 1999
- journal article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 27 (Supplement) , 33A
- https://doi.org/10.1097/00003246-199901001-00024
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: